Skip to main content
Top
Published in: European Journal of Trauma and Emergency Surgery 1/2012

01-02-2012 | Review Article

Evidence for improved outcome following use of hemostatic fibrin sealants in HPB surgery?

Author: R. Andersson

Published in: European Journal of Trauma and Emergency Surgery | Issue 1/2012

Login to get access

Abstract

Introduction

The development of fibrin sealants has been progressing; they are now often applied as fibrinogen-coated collagen patches.

Materials and methods

The concept has been increasingly applied in hepato-pancreato-biliary surgery, for example, following liver resection, and to some extent also in pancreatic surgery, both in order to reinforce the pancreatic anastomosis at pancreaticoduodenectomy and to seal the pancreatic stump following distal pancreatectomy.

Conclusion

High quality evidence in the form of major prospective, randomized clinical studies is still lacking on in the field of HPB. There is also an the absence of proper cost-utility analyses.
Literature
1.
2.
go back to reference Spotnitz WD. Fibrin sealant in the United States: clinical use at the University of Virginia. Thromb Haemost. 1995;74:482–5.PubMed Spotnitz WD. Fibrin sealant in the United States: clinical use at the University of Virginia. Thromb Haemost. 1995;74:482–5.PubMed
3.
go back to reference Busuttil RW. A comparison of antifibrinolytic agents used in hemostatic fibrin sealants. J Am Coll Surg. 2003;197:1021–8.PubMedCrossRef Busuttil RW. A comparison of antifibrinolytic agents used in hemostatic fibrin sealants. J Am Coll Surg. 2003;197:1021–8.PubMedCrossRef
4.
go back to reference Schiele U, Kuntz G, Riegler A. Haemostyptic preparations on the basis of collagen alone and as fixed combination with fibrin glue. Clin Mater. 1992;9:169–77.PubMedCrossRef Schiele U, Kuntz G, Riegler A. Haemostyptic preparations on the basis of collagen alone and as fixed combination with fibrin glue. Clin Mater. 1992;9:169–77.PubMedCrossRef
5.
go back to reference Erdogan D, van Gulik TM. Evolution of fibrinogen-coated collagen patch for use as a topical hemostatic agent. J Biomed Mater Res Part B Appl Biomater. 2008;85B:272–8.CrossRef Erdogan D, van Gulik TM. Evolution of fibrinogen-coated collagen patch for use as a topical hemostatic agent. J Biomed Mater Res Part B Appl Biomater. 2008;85B:272–8.CrossRef
6.
go back to reference Frilling A, Stavrou G, Mischinger HJ, de Hemptinne B, Rokkjaer M, Klempnauer J, Thörne A, Gloor B, Beckebaum S, Ghaffar MFA, Broelsch CE. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomized prospective trial. Langenbecks Arch Surg. 2005;390:114–20.PubMedCrossRef Frilling A, Stavrou G, Mischinger HJ, de Hemptinne B, Rokkjaer M, Klempnauer J, Thörne A, Gloor B, Beckebaum S, Ghaffar MFA, Broelsch CE. Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomized prospective trial. Langenbecks Arch Surg. 2005;390:114–20.PubMedCrossRef
7.
go back to reference Berrevoet F, de Hemptinne B. Use of topical hemostatic agents during liver resection. Dig Surg. 2007;24:288–93.PubMedCrossRef Berrevoet F, de Hemptinne B. Use of topical hemostatic agents during liver resection. Dig Surg. 2007;24:288–93.PubMedCrossRef
8.
go back to reference Apestegui C, Breitenstein S, Dutkowski P, Clavien P-A. Control of severe portal bleeding by carrier-bound fibrin sealant. Surg Today. 2009;39:363–5.PubMedCrossRef Apestegui C, Breitenstein S, Dutkowski P, Clavien P-A. Control of severe portal bleeding by carrier-bound fibrin sealant. Surg Today. 2009;39:363–5.PubMedCrossRef
9.
go back to reference Dregelid E, Ramnefjell MP, Erichsen C, Christensen BJ, Rawal R. Effective hemostasis in severe mesenteric vein laceration with TachoSil®, using a low- or non-thrombogenic patch to prevent TachoSil-induced thrombosis. Eur J Trauma Emerg Surg. 2008;34:177–80.CrossRef Dregelid E, Ramnefjell MP, Erichsen C, Christensen BJ, Rawal R. Effective hemostasis in severe mesenteric vein laceration with TachoSil®, using a low- or non-thrombogenic patch to prevent TachoSil-induced thrombosis. Eur J Trauma Emerg Surg. 2008;34:177–80.CrossRef
10.
go back to reference Lacanna F, Brunati A, Reding R. A new biological mesh for cut surface hemostasis in liver transplantation using technical variants. Pediatr Transplant. 2008;12:520–1.PubMedCrossRef Lacanna F, Brunati A, Reding R. A new biological mesh for cut surface hemostasis in liver transplantation using technical variants. Pediatr Transplant. 2008;12:520–1.PubMedCrossRef
11.
go back to reference Erdogan D, de Graaf W, van Gulik TM. Adhesive strength of fibrinogen-coated collagen patch or liquid fibrin sealant in an experimental liver resection model in pigs. Eur Surg Res. 2008;41:298–302.PubMedCrossRef Erdogan D, de Graaf W, van Gulik TM. Adhesive strength of fibrinogen-coated collagen patch or liquid fibrin sealant in an experimental liver resection model in pigs. Eur Surg Res. 2008;41:298–302.PubMedCrossRef
12.
go back to reference Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, Colonna JO II, Heaton N, Mirza D, Adams R, Rees M, Lloyd D. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg. 2004;139:1148–54.PubMedCrossRef Schwartz M, Madariaga J, Hirose R, Shaver TR, Sher L, Chari R, Colonna JO II, Heaton N, Mirza D, Adams R, Rees M, Lloyd D. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg. 2004;139:1148–54.PubMedCrossRef
13.
go back to reference Figueras J, Llado L, Miro M, Ramos E, Torras J, Fabregat J, Serrano T. Application of fibrin glue sealant after hepatectomy does not seem justified. Results of a randomized study in 300 patients. Ann Surg. 2007;245:536–42.PubMedCrossRef Figueras J, Llado L, Miro M, Ramos E, Torras J, Fabregat J, Serrano T. Application of fibrin glue sealant after hepatectomy does not seem justified. Results of a randomized study in 300 patients. Ann Surg. 2007;245:536–42.PubMedCrossRef
14.
go back to reference Couto J, Kroczek B, Requena R, Lerner R. Autologous fibrin glue as a sealant of the common bile duct. Surgery. 1987;101:354–6.PubMed Couto J, Kroczek B, Requena R, Lerner R. Autologous fibrin glue as a sealant of the common bile duct. Surgery. 1987;101:354–6.PubMed
15.
go back to reference Wise PE, Wudel LJ, Belous AE, Allos TM, Kuhn SJ, Feurer ID, Washington MK, Pinson CW, Chapman WC. Biliary reconstruction is enhanced with a collagen-polyethylene glycol sealant. Am Surg. 2002;68:553–62.PubMed Wise PE, Wudel LJ, Belous AE, Allos TM, Kuhn SJ, Feurer ID, Washington MK, Pinson CW, Chapman WC. Biliary reconstruction is enhanced with a collagen-polyethylene glycol sealant. Am Surg. 2002;68:553–62.PubMed
16.
go back to reference Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, The International Study Group of Pancreatic Fistula, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.PubMedCrossRef Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, The International Study Group of Pancreatic Fistula, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.PubMedCrossRef
17.
go back to reference Balcom JHT, Rattner DW, Warshaw AL, Chang Y, Fernandez-del Castillo C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg. 2001;136:391–8.PubMedCrossRef Balcom JHT, Rattner DW, Warshaw AL, Chang Y, Fernandez-del Castillo C. Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization. Arch Surg. 2001;136:391–8.PubMedCrossRef
18.
go back to reference Vin Y, Sima CS, Getrajdman GI, Brown KT, Covey A, Brennan MF, Allen PJ. Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg. 2008;207:490–8.PubMedCrossRef Vin Y, Sima CS, Getrajdman GI, Brown KT, Covey A, Brennan MF, Allen PJ. Management and outcomes of postpancreatectomy fistula, leak, and abscess: results of 908 patients resected at a single institution between 2000 and 2005. J Am Coll Surg. 2008;207:490–8.PubMedCrossRef
19.
go back to reference Callery MP, Pratt WB, Vollmer CM Jr. Prevention and management of pancreatic fistula. J Gastrointest Surg. 2009;13:163–73.PubMedCrossRef Callery MP, Pratt WB, Vollmer CM Jr. Prevention and management of pancreatic fistula. J Gastrointest Surg. 2009;13:163–73.PubMedCrossRef
20.
go back to reference Goh BKP, Tan YM, Chung YFA, Cheow PC, Chan WH, Chow PKH, Soo KC, Wong WK. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula. A 21-year experience at a single institution. Arch Surg. 2008;143:956–65.PubMedCrossRef Goh BKP, Tan YM, Chung YFA, Cheow PC, Chan WH, Chow PKH, Soo KC, Wong WK. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula. A 21-year experience at a single institution. Arch Surg. 2008;143:956–65.PubMedCrossRef
21.
go back to reference Rodriguez JR, Germez SS, Pandharipande PV, Gazelle GS, Thayer SP, Warshaw AL, Fernandez-del-Castillo C. Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg. 2006;141:361–6.PubMedCrossRef Rodriguez JR, Germez SS, Pandharipande PV, Gazelle GS, Thayer SP, Warshaw AL, Fernandez-del-Castillo C. Implications and cost of pancreatic leak following distal pancreatic resection. Arch Surg. 2006;141:361–6.PubMedCrossRef
22.
go back to reference Shrikhande SV, D’Souza MA. Pancreatic fistula after pancreatectomy: evolving definitions, preventive strategies and modern management. World J Gastroenterol. 2008;14:5789–96.PubMedCrossRef Shrikhande SV, D’Souza MA. Pancreatic fistula after pancreatectomy: evolving definitions, preventive strategies and modern management. World J Gastroenterol. 2008;14:5789–96.PubMedCrossRef
23.
go back to reference D’Andrea AA, Costantino V, Sperti C, Pedrazzoli S. Human fibrin sealant in pancreatic surgery: is it useful in preventing fistulas? A prospective randomized study. Ital J Gastroenterol. 1994;26:283–6.PubMed D’Andrea AA, Costantino V, Sperti C, Pedrazzoli S. Human fibrin sealant in pancreatic surgery: is it useful in preventing fistulas? A prospective randomized study. Ital J Gastroenterol. 1994;26:283–6.PubMed
24.
go back to reference Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, Yeo CJ. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2004;8:766–74.PubMedCrossRef Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, Yeo CJ. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2004;8:766–74.PubMedCrossRef
25.
go back to reference Fisher WE, Chai C, Hodges SE, Wu MF, Hilsenbeck SG, Brunicardi FC. Effect of BioGlue® on the incidence of pancreatic fistula following pancreas resection. J Gastrointest Surg. 2008;12:882–90.PubMedCrossRef Fisher WE, Chai C, Hodges SE, Wu MF, Hilsenbeck SG, Brunicardi FC. Effect of BioGlue® on the incidence of pancreatic fistula following pancreas resection. J Gastrointest Surg. 2008;12:882–90.PubMedCrossRef
26.
go back to reference Schulick RD. Complications after pancreaticoduodenectomy: intraabdominal abscess. J Hepatobiliary Pancreat Surg. 2008;15:252–6.PubMedCrossRef Schulick RD. Complications after pancreaticoduodenectomy: intraabdominal abscess. J Hepatobiliary Pancreat Surg. 2008;15:252–6.PubMedCrossRef
27.
go back to reference Suc B, Msika S, Fingerhut A, Fourtanier G, Hay JM, Holmières F, Sastre B, Fagniez PL, The French Associations for Surgical Research. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection. Prospective randomized trial. Ann Surg. 2003;237:57–65.PubMedCrossRef Suc B, Msika S, Fingerhut A, Fourtanier G, Hay JM, Holmières F, Sastre B, Fagniez PL, The French Associations for Surgical Research. Temporary fibrin glue occlusion of the main pancreatic duct in the prevention of intra-abdominal complications after pancreatic resection. Prospective randomized trial. Ann Surg. 2003;237:57–65.PubMedCrossRef
28.
go back to reference Fingerhut A, Veyrie N, Ata T, Alexakis N, Leandros E. Use of sealants in pancreatic surgery: critical appraisal of the literature. Dig Surg. 2009;26:7–14.PubMedCrossRef Fingerhut A, Veyrie N, Ata T, Alexakis N, Leandros E. Use of sealants in pancreatic surgery: critical appraisal of the literature. Dig Surg. 2009;26:7–14.PubMedCrossRef
Metadata
Title
Evidence for improved outcome following use of hemostatic fibrin sealants in HPB surgery?
Author
R. Andersson
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
European Journal of Trauma and Emergency Surgery / Issue 1/2012
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-010-0031-z

Other articles of this Issue 1/2012

European Journal of Trauma and Emergency Surgery 1/2012 Go to the issue